Entegris (ENTG) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
1 May, 2026Executive summary
Q1 2026 net sales rose 5% year-over-year to $811.9 million, driven by advanced logic, memory, and manufacturing process demand, with both Materials Solutions (MS) and Advanced Purity Solutions (APS) segments contributing to growth.
GAAP net income increased 46.3% year-over-year to $92.0 million ($0.60 per diluted share), and non-GAAP net income was $132.5 million ($0.86 per share), both exceeding guidance.
Adjusted EBITDA reached $226.1 million (27.8% margin), with adjusted gross margin, EBITDA margin, and non-GAAP EPS all above guidance.
Strong free cash flow of $144 million (18% of sales) enabled $50 million term loan repayment and supported deleveraging.
Appointment of Sukhi Nagesh as CFO effective May 2026, bringing semiconductor and financial expertise.
Financial highlights
Gross margin improved to 46.9% (GAAP and non-GAAP), including 50 bps of one-time items, and operating income rose to $141.6 million.
Free cash flow was $143.5 million, with cash and cash equivalents at $442.7 million at quarter end.
Net debt at quarter end was $3.3 billion, net leverage 3.6x, with a target of ~3x by year-end.
Dividend payments totaled $15.4 million for the quarter.
CapEx expected to be $250 million for 2026, below 2025 levels.
Outlook and guidance
Q2 2026 sales expected between $815–$845 million, with GAAP EPS $0.53–$0.61 and non-GAAP EPS $0.76–$0.84; adjusted EBITDA margin projected at 27.0%–28.0%.
Q2 gross margin guided at 46.25–47.25%, a 200+ bps year-over-year improvement.
Q3 revenue expected to grow ~5% sequentially from Q2 midpoint, with 8% year-over-year growth.
Full-year 2026: net interest expense slightly below $190 million, non-GAAP tax rate ~15%, CapEx $250 million, depreciation ~$140 million.
Management expects continued benefits from increased useful lives of property, plant, and equipment, reducing annual depreciation by approximately $73 million in 2026.
Latest events from Entegris
- Abstentions and broker non-votes now count against eliminating supermajority requirements.ENTG
Proxy filing26 Mar 2026 - Annual meeting to vote on directors, compensation, auditor, and key shareholder rights changes.ENTG
Proxy filing23 Mar 2026 - Proxy covers leadership transition, governance reforms, and performance-based compensation changes.ENTG
Proxy filing23 Mar 2026 - Strategic growth, governance reforms, and enhanced ESG drive long-term value creation.ENTG
Proxy Filing6 Mar 2026 - Q4 2025 delivered strong sales and margins, with robust 2026 guidance and ongoing deleveraging.ENTG
Q4 202510 Feb 2026 - Q2 sales rose sequentially with strong margins; Q3 guidance and investments support further growth.ENTG
Q2 20242 Feb 2026 - Adjusted sales up 7% year-over-year; Q4 outlook signals margin strength and cost savings.ENTG
Q3 202417 Jan 2026 - Q4 2024 delivered double-digit adjusted sales growth and margin expansion, beating guidance.ENTG
Q4 20248 Jan 2026 - Q2 2025 sales were $792.4M, with Q3 non-GAAP EPS guided at $0.68–$0.75.ENTG
Q2 202517 Dec 2025